Related Experiment Video
Updated: Aug 17, 2026
Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
Published on: November 26, 2010
Experimental model of pulmonary metastasis treatment with IFNalpha
Cristina Martínez1, Vicente Vicente, M Josefa Yáñez
1Department of Pathology, Faculty of Medicine, University of Murcia, 30100 Espinardo, Murcia, Spain. crismart@um.es
Abstract:
Melanoma shows the high rates of mortality, preferentially by metastasis, and the failure of chemotherapy. We inoculated 30 B16F10 Swiss mice with 5 x 10(5) melanocytes. The mice were then inoculated with 150,000; 300,000; 600,000 and 1,200,000 IU/mouse of interferon alpha. A count of the metastatic nodules of the lung surface and the microscopic study were made by image analysis on five histological sections, calculating the implantation percentage and tumoral growth and invasion index. Treatment with the three highest doses of interferon alpha resulted in a dose-dependent reduction of the number of metastatic nodules and invaded area. A correlation existing between the parameters studied and the different antitumoral effects observed.
Insights
Interferon alpha effectively reduced melanoma metastasis in mice. Higher doses showed a dose-dependent decrease in lung nodules and tumor invasion, indicating therapeutic potential.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Melanoma is a deadly cancer with high mortality rates, primarily due to metastasis.
- Chemotherapy often fails to treat melanoma effectively.
- Interferon alpha is being investigated for its potential anti-cancer properties.
Purpose of the Study:
- To evaluate the efficacy of interferon alpha in reducing melanoma metastasis.
- To determine the dose-dependent effects of interferon alpha on tumor growth and invasion.
Main Methods:
- B16F10 melanoma cells were inoculated into Swiss mice.
- Mice received varying doses of interferon alpha (150,000 to 1,200,000 IU/mouse).
- Lung metastasis was quantified using image analysis of histological sections, calculating implantation percentage and invasion index.
Main Results:
- Treatment with the three highest doses of interferon alpha significantly reduced the number of metastatic lung nodules.
- A dose-dependent reduction in the invaded tumor area was observed.
- A correlation was found between interferon alpha dosage and observed anti-tumoral effects.
Conclusions:
- Interferon alpha demonstrates significant anti-metastatic effects against melanoma in a preclinical model.
- The study suggests a dose-dependent therapeutic window for interferon alpha in melanoma treatment.
- Further research into interferon alpha as a melanoma therapy is warranted.
More Related Videos
13:37A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
Published on: March 12, 2014
05:59Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury
Published on: August 30, 2019